Biomarker amplification by serum carrier protein binding

Disease Markers

Volumn 19, Issue 1, 2004, Pages 1-10

  Mehta, Arpita I ^a,b,c   Ross, Sally ^b,c   Lowenthal, Mark S ^b   Fusaro, Vincent ^b,c   Fishman, David A ^d   Petricoin III, Emanuel F ^b   Liotta, Lance A ^b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CARRIER PROTEIN; PROTEOME;

ARTICLE; CLEARANCE; CORRELATION ANALYSIS; FRACTIONATION; MASS SPECTROMETRY; MOLECULAR WEIGHT; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BINDING; SERUM;

FALLOPIA;

EID: 1142291302     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/104879     Document Type: Article

References (34)

1. N.L. Anderson and N.G. Anderson, The human plasma proteome: history, character, and diagnostic prospects, Mol Cell Proteomics 1 (2002), 845-867.
2. J.B. Ward Jr and R.E. Henderson, Identification of needs in biomarker research, [Review], Environ Health Perspect 104 (1996), 895-900.
3. R. Etzioni, N. Urban, S. Ramsey, M. McIntosh, S. Schwartz, B. Reid, J. Radich, G. Anderson and L. Hartwell, Early detection: The case for early detection, Nat Rev Cancer 3(4) (April 2003), 243-252.
4. Y.Y. Wang, P. Cheng and D.W. Chan, A simple affinity spin tube filter method for removing high-abundant common proteins or enriching low-abundant biomarkers for serum proteomic analysis, Proteomics 3(3) (March 2003), 243-248.
5. H.J. Issaq, T.P. Conrads, G.M. Janini and T.D. Veenstra, Methods for fractionation, separation and profiling of proteins and peptides, Electrophoresis 23 (2002), 3048-3061.
6. D.L. Rothemund, V.L. Locke, A. Liew, T.M. Thomas, V. Wasinger and D.B. Rylatt, Depletion of the highly abundant protein albumin from human plasma using the Gradiflow, Proteomics 3(3) (March 2003), 279-287.
7. E.F. Petricoin III and L.A. Liotta, Mass Spectrometry - Based Diagnostics: The Upcoming Revolution in Disease Detection [Editorial], Clin Chem 49 (2003).
8. B.L. Adam, A. Vlahou, O.J. Semmes and G.L. Wright Jr, Proteomic approaches to biomarker discovery in prostate and bladder cancers, [Review], Proteomics 1 (2001), 1264-1270.
9. E.F. Petricoin, A.M. Ardekani, B.A. Hitt, P.J. Levine, V.A. Fusaro and S.M. Steinberg et al., Use of proteomic patterns in serum to identify ovarian cancer, Lancet 359 (2002), 572-577.
10. E.F. Petricoin III, G.B. Mills, E.S. Kohn and L.A. Liotta, Proteomic patterns in serum and identification of ovarian cancer [Reply], Lancet 360 (2002), 170-171.
11. J. Li, Z. Zhang, J. Rosenzweig, Y.Y. Wang and D.W. Chan, Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer, Clin Chem 48 (2002), 1296-1304.
12. E.F. Petricoin, D.K. Ornstein, C.P. Paweletz, A. Ardekani, P.S. Hackett and B.A. Hitt et al., Serum proteomic patterns for detection of prostate cancer, J Natl Cancer Inst 94 (2002), 1576-1578.
13. B.L. Adam, Y. Qu, J.W. Davis, M.D. Ward, M.A. Clements and L.H. Cazares et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men, Cancer Res 62 (2002), 3609-3614.
14. B.A. Lollo, S. Harvey, J. Liao, A.C. Stevens, R. Wagenknecht and R. Sayen et al. Improved two-dimensional gel electrophoresis representation of serum proteins by using Proto-Clear, Electrophoresis 20 (1999), 854-859.
15. A.B. Kantor, Comprehensive phenotyping and biological marker discovery, [Review], Dis Markers 18 (2002), 91-97.
16. W.H. McDonald and J.R. Yates 3rd, Shotgun proteomics and biomarker discovery, [Review], Dis Markers 18 (2002), 99-105.
17. T. Bonk and A. Humeny, MALDI-TOF-MS analysis of protein and DNA, [Review], Neuroscientist 7 (2001), 6-12.
18. S.R. Weinberger, E. Boschetti, P. Santambien and V. Brenac, Surface-enhanced laser desorption-ionization retentate chromatography mass spectrometry (SELDI-RC-MS): A new method for rapid development of process chromatography conditions, J Chromatogr B Analyt Technol Biomed Life Sci 782 (2002), 307-316.
19. C. Cojocel, K. Maita, K. Baumann and J.B. Hook, Renal processing of low molecular weight proteins, Pflugers Arch 401 (1984), 333-339.
20. T. Maack, Renal handling of low molecular weight proteins, [Review], Am J Med 58 (1975), 57-64.
21. M.S. Dennis, M. Zhang, Y.G. Meng, M. Kadkhodayan, D. Kirchhofer and D. Combs et al., Albumin binding as a general strategy for improving the pharmacokinetics of proteins, J Biol Chem 277 (2002), 35035-35043.
22. P. Yeh, D. Landais, M. Lemaitre, I. Maury, J.Y. Crenne and J. Becquart et al., Design of yeast-secreted albumin derivatives for human therapy: Biological and antiviral properties of a serum albumin-CD4 genetic conjugate, Proc Natl Acad Sci USA 89 (1992), 1904-1908.
23. B.L. Osborn, H.S. Olsen, B. Nardelli, J.H. Murray, J.X. Zhou and A. Garcia et al., Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys, J Pharmacol Exp Ther 303 (2002), 540-548.
24. W.M. Saltzman, Drug delivery: Engineering principles for drug therapy, Oxford: University Press, 2001, pp. 175-196.
25. J.D. Veldhuis, M.L. Johnson, L.M. Faunt, M. Mercado and G. Baumann, Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications, J Clin Invest 91 (1993), 629-641.
26. Y. Ding, B. Lin and C.W. Huie, Binding studies of porphyrins to human serum albumin using affinity capillary electrophoresis, Electrophoresis 22 (2001), 2210-2216.
27. V. Ravery, A. Meulemans and L. Boccon-Gibod, Clearance of free and total serum PSA after prostatic surgery, Eur Urol 33 (1998), 251-254.
28. M.B. Daly and R.F. Ozols, The search for predictive patterns in ovarian cancer: Proteomics meets bioinformatics, Cancer Cell 1 (2002), 111-112.
29. B.N. Swanson, Delivery of high-quality biomarker assays, [Review], Dis Markers 18 (2002), 47-56.
30. N.B. Kiviat and C.W. Critchlow, Novel approaches to identification of biomarkers for detection of early stage cancer, [Review], Dis Markers 18 (2002), 73-81.
31. M.S. Tockman, P.K. Gupta, N.J. Pressman and J.L. Mulshine, Considerations in bringing a cancer biomarker to clinical application, [Review], Cancer Res 52 (1992), 2711s-2718s.
32. N.L. Simone, A.T. Remaley, L. Charboneau, E.F. Petricoin, J.W. Glickman and M.R. Emmert-Buck et al., Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection, Am J Pathol 156 (2000), 445-452.
33. T. Okegawa, H. Noda, K. Nutahara and E. Higashihara, Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer, Eur Urol 38 (2000), 380-387.
34. R.G. Reed, R.C. Feldhoff, O.L. Clute and T. Peters Jr, Fragments of bovine serum albumin produced by limited proteolysis. Conformation and ligand binding, Biochemistry 14 (1975), 4578-4583.